mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |